Related Experiment Video
Updated: Oct 10, 2025

08:17
A Mouse Model of Orthopedic Surgery to Study Postoperative Cognitive Dysfunction and Tissue Regeneration
Published on: February 27, 2018
16.6K
Neuroinflammation-mediated mitochondrial dysregulation involved in postoperative cognitive dysfunction
Yan Yang1, Yue Liu1, Jixiang Zhu1
1Department of Anesthesiology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu Province, 210008, China.
Free Radical Biology & Medicine
|December 7, 2021
Summary
Neuroinflammation after surgery impairs brain function, leading to cognitive decline. This study reveals that targeting neuronal metabolism, not dynamin-related protein 1 (DRP1) directly, can protect against this damage.
Area of Science:
- Neuroscience
- Cell Biology
- Pathology
Background:
- Postoperative cognitive dysfunction (POCD) is linked to neuroinflammation following surgery.
- Impaired mitochondrial function is a hallmark of neuronal degeneration in POCD.
- Dynamin-related protein 1 (DRP1) regulates mitochondrial dynamics and synapse formation.
Purpose of the Study:
- To investigate the role of DRP1-regulated mitochondrial dynamics in POCD.
- To explore the relationship between DRP1, mitochondrial function, and neuroinflammation in POCD.
Main Methods:
- Aged mice underwent laparotomy; primary neurons and SH-SY5Y cells were exposed to tumor necrosis factor (TNF).
- Assessed DRP1 activation, mitochondrial fragmentation, and mitochondrial function.
- Utilized DRP1 inhibitor (Mdivi-1), DRP1 knockdown (siRNA), and calcineurin inhibitor (FK506).
Main Results:
- Surgery and TNF exposure increased DRP1 activation and mitochondrial fragmentation.
- Mdivi-1 reduced fragmentation but impaired mitochondrial function and neurite growth.
- FK506 mitigated mitochondrial dysfunction and improved neurite growth and learning ability, independent of DRP1.
Conclusions:
- DRP1 activation contributes to mitochondrial dysfunction in POCD, but direct inhibition is detrimental.
- Calcineurin activity mediates DRP1 activation and subsequent mitochondrial dysfunction.
- Modulating neuronal metabolism via calcineurin inhibition offers a promising therapeutic strategy for POCD.

